Drugs for Neglected Diseases Contract Renewal

Best Science for the Most Neglected

Epichem is excited to announce that our partnership with the Drugs for Neglected Diseases Initiative, DNDi, to develop life-saving medicines for people with neglected diseases around the world, will continue in 2022.

The contract renewal will see Epichem continue to provide its synthetic and medicinal chemistry expertise to support DNDi’s drug discovery projects.

Epichem’s CEO, Mr Colin La Galia said “We are delighted that the contract with DNDi has been renewed for another year and excited by what we can achieve together in partnership and collaboration with our dedicated team of chemists.

This will mark our 14th consecutive year with DNDi, supporting their important work and we look forward to continuing our long-standing and important relationship with them.”


Leave a Comment